← Open Payments lookup

JOCELYN URIOSTEGUI: Open Payments

NPI 1912475633 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,829 in 80 payments from 24 companies in 2025. Trend: 2023 $1,332 · 2024 $1,804 · 2025 $1,829

Food & beverage: $1,829
CompanyPaymentsAmount
Novo Nordisk Inc14$286
Lilly USA, LLC13$278
SANOFI-AVENTIS U.S. LLC5$143
Boehringer Ingelheim Pharmaceuticals, Inc.4$96
Amphastar Pharmaceuticals, Inc.5$95
CeQur Corporation1$90
Amneal Pharmaceuticals LLC4$85
Tandem Diabetes Care, Inc.4$85
Amgen Inc.4$79
Bayer Healthcare Pharmaceuticals Inc.3$77

Products named: JARDIANCE, MOUNJARO, TZIELD, Ozempic, CeQur Simplicity, UNITHROID, t:slim X2 Insulin Pump with Control-IQ, Kerendia.

Industry payments across TX — which companies pay providers there.